Expression of p16 (INK4a), cytokeratin 19, and Ki-67 in canine laryngeal squamous cell carcinoma

Open access


The study aimed at morphological and immunohistochemical characteristics of laryngeal squamous cell carcinomas and their metastases in canine lymph nodes and lungs. Tissue sections were stained using classical technique with haematoxylin and eosin. In addition, immunohistochemical studies were performed with p16, cytokeratin, and Ki-67 antibodies. An expression of all examined antigens was detected in laryngeal tumours, while in tumour metastases only expression of p16 protein and cytokeratin was demonstrated. The results pointed to higher proliferative potential of the primary tumour than of their metastases.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. Agoff S.N. Lin P. Morihara J. Mao C. Kiviat N.B. Koutsky L.A.: p16INK4a expression correlates with degree of cervical neoplasia: A comparison with Ki-67 expression and detection of high-risk HPV types. Mod Pathol 2003 16 665-673.

  • 2. Barnard N.J. Hall P.A. Lemoine N.R. Kadar N.: Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables. J Pathol 1987 152 287-295.

  • 3. Beaumont P.R. O’Brien J.B. Allen H.L. Tucker J.A.: Mast cell sarcoma of the larynx in a dog: a case report. J Small Anim Pract 1979 20 19-25.

  • 4. Brodey R.S. O’Brien J. Berg P. Roszel J.F.: Osteosarcoma of the upper airway in the dog. J Am Vet Med Assoc 1969 155 1460-1464.

  • 5. Carlisle C.H. Biery D.N. Thrall D.E.: Tracheal and laryngeal tumors in the dog and cat: Literature review and 13 addictional patients. Vet Radiol 1991 32 229-265.

  • 6. Chandrashekaraiah G.B. Rao S. Munivenkatappa B.S. Mathur K.Y.: Canine squamous cell carcinoma: a review of 17 cases. Braz J Vet Pathol 2011 4 79-86.

  • 7. Coggins C.R.E.: A review of chronic inhalation studies with mainstream cigarette smoke in hamsters dogs and nonhuman primates. Toxicol Pathol 2001 29 550-557.

  • 8. Cooper D. Schermer A. Sun T.T.: Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: strategies applications and limitations. Lab Invest 1985 52 243-256.

  • 9. Dungworth D.L. Hauser B. Hahn F.F. Wilson D.W. Haenichen T. Harkema J.R.: Histological classification of tumors of the respiratory system of domestic animals. WHO Second Series 1999 6 23-24.

  • 10. Eshkoor S.A. Ismail1 P. Rahman S.A. Mirinargesil M. Oshkour S.A.: Increased protein expression of p16 and cyclin D1 in squamous cell carcinoma tissues. BioSci Trends 2009 3 105-109.

  • 11. Galus R. Włodarski K.: Importance of the cytokeratins in cancer diagnosis. Pol Merk Lek 2007 135 209-211.

  • 12. Gerdes J. Lelle R.J. Pickartz H. Heidenreich W. Schwarting R. Kurtsiefer L. Stauch G. Stein H.: Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67. J Clin Pathol 1986 39 977-980.

  • 13. Giziński S. Boryczko Z. Katkiewicz M. Bostedt H.: Ki-67 protein as a prognostic factor in mammary gland tumors in female dogs. Med Weter 2003 59 888-891.

  • 14. Hargis A.M. Thomassen R.W. Phemister R.D.: Chronic dermatosis and cutaneous squamous cell carcinoma in the Beagle dog. Vet Pathol 1977 14 218-228.

  • 15. Iwaya K. Mukai K.: Accumulation of ubiquitin-conjugated cytokeratin fragments in tumor cells. Semin Cancer Biol 2005 15 309-318.

  • 16. Jones D.L.: Squamous cell carcinoma of the larynx and pharynx in horses. Cornell Vet 1994 84 15-24.

  • 17. Kaufmann O. Fietze E. Mengs J. Dietel M.: Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol 2001 116 823-830.

  • 18. Koenig A. Bianco S. Fosmire S. Wojcieszyn J. Modiano J.: Expression and significance of p53 rb p21/waf-1 p16/ink-4a and PTEN tumor suppressors in canine melanoma. Vet Pathol 2002 39 458-472.

  • 19. Kozaki M. Nakamura Y. Iguchi M. Kano R. Watanabe S. Fujiwara K. Hasegawa A.: Immunohistochemical analysis of cytokeratin expression in dog skin. J Vet Med Sci 2001 63 1-4.

  • 20. Kreipe H. Heidebrecht H.J. Hansen S. Rohlk W. Kubbies M. Wacker H.H. Tiemann M. Radzun H.J. Parwaresch R.: A new proliferation-associated nuclear antigen detectable in paraffin- embedded tissues by the monoclonal antibody Ki-S1. Am J Pathol 1993 142 3-9.

  • 21. Lascelles B.D.X. Parry A.T. Stidworthy M.F. Dobson J.M. White R.A.S.: Squamous cell carcinoma of the nasal planum in 17 dogs. Vet Rec 2000 147 473-476.

  • 22. Meuten D.J.: Tumors in domestic animals. Iowa State Press 2002 pp. 51-52 377-378.

  • 23. Moll R. Franke W.W. Schiller D.L. Geiger B. Krepler R.: The catalog of human cytokeratins: patterns of expression in normal epithelia tumors and cultured cells. Cell 1982 31 11-24.

  • 24. Morris J. Dobson J.: Small Animal Oncology edited by Blackwell Science Iowa 2001 pp. 144-147.

  • 25. Myung N. Kim M. Chung I. Kim H. Jang J.: Loss of p16 and p27 is associated with progression of human gastric cancer. Cancer Lett 2000 153 129-136.

  • 26. Nazifi S. Tamadon A. Meimandi Parizi A.H. Mahjoor A. Bigham A.: Squamous cell carcinoma of the larynx in a Pekingese dog. Comp Clin Pathol 2006 15 199-202.

  • 27. Nowak M. Madej J.A. Dzięgiel P.: Correlation between the expression of mcm-3 protein and ki-67 antigen in mammary adenocarcinomas of dogs (short communication). Bull Vet Inst Pulawy 2008 52 701-705.

  • 28. Nowak M. Madej J.A. Dzięgiel P.: Expression of metallothionein and its correlation with Ki-67 antigen in bitch’s mammary gland adenocarcinomas. Med Weter 2006 62 427-431.

  • 29. Nowak M. Madej J.A. Dzięgiel P.: Extent of metallothionein expression in correlation with expression of Ki-67 antigen in soft tissue fibrosarcoma in dogs. Bull Vet Inst Pulawy 2007 51 139-144.

  • 30. Nowak M. Madej. J.A. Dzięgiel P.: Correlation between the expression of HER2 receptor and Ki-67 antigen in mammary adenocarcinomas in bitches. Bull Vet Inst Pulawy 2005 49 337-342.

  • 31. Orlow I. Lacombe L. Hannon G.J. Serrano M. Pellicer I. Dalbagni G. Reuter V.E. Zhang Z.F. Beach D. Cordon-Cardo C.: Deletion of the p16 and p15 genes in human bladder tumors. J Natl Cancer Inst 1995 87 1524-1529.

  • 32. Pass D.A. Huxtable C.R. Cooper B.J. Watson A.D.J. Thompson R.: Canine laryngeal oncocytomas. Vet Pathol 1980 17 672-677.

  • 33. Rocco J.W. Sidransky D.: p16(MTS-1/CDKN2/INK4a) in cancer progression. Exp Cell Res 2001 264 42-55.

  • 34. Rocco A. Schandl L. Nardone G. Tulassay Z. Staibano S. Malfertheiner P. Ebert M.: Loss of expression of tumor suppressor p16(INK4) protein in human primary gastric cancer is related to the grade of differentiation. Dig Dis 2002 20 102-105.

  • 35. Rotstein D.S. Govett P. Wolfe B.Ł Laryngeal squamous cell carcinoma in a North American black bear (Ursus americanus). J Zoo Wildl Med 2005 36 543-545.

  • 36. Saik J.E. Toll S.L. Diters R.W. Goldschmidt M.H.: Canine and feline laryngeal neoplasia: a 10-year survey. J Am Anim Hosp Assoc 1986 22 359-365.

  • 37. Sapierzyński R.: Practical oncology in dogs and cats. Edited by Elsevier Wroclaw 2010 pp. 79-85.

  • 38. Schwarz P.D. Willer R.I.: Urinary bladder neoplasia in the dog and cat. Prob Vet Med 1989 168 425-427.

  • 39. Silva S.D. Nonogaki S. Soares F.A. Kowalski L.P.: p16 (INK4a) has clinicopathological and prognostic impact on oropharynx and larynx squamous cell carcinoma. Braz J Med Biol Res 2012 45 1327-1333.

  • 40. Smith E.M. Rubenstein L.M. Hoffman H. Haugen T.H. Turek L.P.: Human papillomavirus p16 and p53 expression associated with survival of head and neck cancer. Infect Agent Cancer 2010 5 4-13.

  • 41. Stachura J. Domagała W.: Pathology - word about the disease. Vol II PAU Kraków 2005 pp. 716-722.

  • 42. Strafuss A.C. Cook J.E. Smith J.E.: Squamous cell carcinoma in dogs. J Am Vet Med Assoc 1976 168 425-427.

  • 43. Walter J.H.: Cytokeratins in the canine epidermis. Vet Dermatol 2001 12 81-87.

  • 44. Weinberger P.M. Yu Z. Haffty B.G. Kowalski D. Harigopal M. Sasaki C. Rimm D.L. Psyrri A.: Prognostic significance of p16 protein levels in oropharyngeal squamous cell cancer. Clin Cancer Res 2004 10 5684-5691.

Journal information
Impact Factor

IMPACT FACTOR 2018: 0,829
5-year IMPACT FACTOR: 0,938

CiteScore 2018: 0.68

SCImago Journal Rank (SJR) 2018: 0.291
Source Normalized Impact per Paper (SNIP) 2018: 0.501

Cited By
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 201 79 6
PDF Downloads 66 29 0